Dear Ms. Sawhney and Dr. Filice

The New England Endocrine Alliance (NEEA) is comprised of over 450 members of the endocrine community. We are committed to providing the best possible care to our patients with diabetes and other endocrine conditions. We are involved in the care of many women with diabetes in pregnancy. We are concerned with the recent change to the HSN formulary requiring a PA for any NPH insulin whereas Mass Health formulary covers Novolin N without need for a PA.

VIEW FULL LETTER

Dear Dr. Muzina and Dr. Schlott,

The New England Endocrine Alliance is comprised of over 450 members of the endocrine community.  We are committed to providing the best possible care to our patients with diabetes and other endocrine conditions.  We treat many patients with male hypogonadism with testosterone therapy.

We recently have had patients with male hypogonadism on Wellsense insurance who have had difficulty with testosterone coverage. A recent patient with documented hypogonadism on long term testosterone therapy had a few gaps in his refill history and needed to have two low testosterone levels 3 months apart to have his testosterone therapy coverage resumed again. Disruption of testosterone replacement therapy leads to adverse clinical impacts, including the development of low testosterone levels with clinical signs and symptoms of hypogonadism.

VIEW FULL LETTER

Dear Governor Healey,

The New England Endocrine Alliance (NEEA) is comprised of over 450 members of the endocrine community. We are committed to providing the best possible care to our patients with diabetes and other endocrine conditions. We are very appreciative of your recent proposal to eliminate prior authorizations (PA) thereby reducing administrative burdens faced by medical practices in Massachusetts. We are especially supportive of the proposal that patients with diabetes will no longer need a PA for any service including devices (such as continuous glucose monitors or insulin pumps) as well as diabetes medications. Due to the fact that our endocrine practices are greatly affected by current PA requirements, NEEA would be interested in volunteering to assist the Division of Insurance with your proposal.

VIEW FULL LETTER

The New England Endocrine Alliance is please to launch our new website! Direct access will be available at www.newenglandendoalliance.org. Your patience is appreciated as our new management company, Bridges Management, LLC, finalizes the transfer of all content from our old site to our new site. Members will receive an email with their site login and access details in the coming weeks. Check back for new page updates and the latest happenings at NEEA!

Thank you for attending the New England Endocrine Alliance 15th Annual Meeting, held October 28, 2023, in Boston, Massachusetts, and congratulations to the recipients of the Distinguished Member and Distinguished Clinician Awards!

Miguel Ariza, MD (left) presenting Distinguished Member Award to Barry Izenstein, MD (right)

Sun Lee, MD (left) presenting Distinguished Clinician Award to Stephanie Lee, MD (right)

NEEA Board of Directors at the 15th Annual Meeting